PHAR vs. AMYT, GPH, IGC, ARTL, KOD, ORPH, AMPH, ANW, REVB, and MRK
Should you be buying Pharos Energy stock or one of its competitors? The main competitors of Pharos Energy include Amryt Pharma (AMYT), Global Ports (GPH), India Capital Growth (IGC), Alpha Real Trust (ARTL), Kodal Minerals (KOD), Open Orphan (ORPH), Aggregated Micro Power (AMPH), Aberdeen New Thai Investment Trust (ANW), Revolution Beauty Group (REVB), and Marks Electrical Group (MRK). These companies are all part of the "pharmaceutical products" industry.
Pharos Energy vs.
Pharos Energy (LON:PHAR) and Amryt Pharma (LON:AMYT) are both small-cap energy companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.
Amryt Pharma received 221 more outperform votes than Pharos Energy when rated by MarketBeat users. However, 70.97% of users gave Pharos Energy an outperform vote while only 65.68% of users gave Amryt Pharma an outperform vote.
24.4% of Pharos Energy shares are held by institutional investors. 51.3% of Pharos Energy shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Pharos Energy had 1 more articles in the media than Amryt Pharma. MarketBeat recorded 1 mentions for Pharos Energy and 0 mentions for Amryt Pharma. Pharos Energy's average media sentiment score of 1.11 beat Amryt Pharma's score of 0.00 indicating that Pharos Energy is being referred to more favorably in the media.
Amryt Pharma has higher revenue and earnings than Pharos Energy. Pharos Energy is trading at a lower price-to-earnings ratio than Amryt Pharma, indicating that it is currently the more affordable of the two stocks.
Amryt Pharma has a net margin of 0.00% compared to Pharos Energy's net margin of -13.95%. Amryt Pharma's return on equity of 0.00% beat Pharos Energy's return on equity.
Summary
Pharos Energy beats Amryt Pharma on 7 of the 12 factors compared between the two stocks.
Get Pharos Energy News Delivered to You Automatically
Sign up to receive the latest news and ratings for PHAR and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Pharos Energy Competitors List
Related Companies and Tools
This page (LON:PHAR) was last updated on 1/21/2025 by MarketBeat.com Staff
